NSC |
Compound |
Enrichment |
Correlation |
NSC 639541 |
Cyclopentanone, 2-[(4-chlorophenyl)aminomethyl]-5-[(4- hydroxyphenyl)methylene]- |
0.0139796580235794 |
0.60925093 |
NSC 641106 |
Benzenesulfonamide, N-[4-[[(4-carboxypheny)imino]methyl]- 3-methylphenyl]-N-(2-cyanoethyl)- |
0.0139796580235794 |
0.67969029 |
NSC 641245 |
Benzenebutanamide, N-(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)-.alpha.,.gamma.-dioxo-2-(3,4-dihydro- 3,4-dioxo-2-naphthalenyl)- |
0.0139796580235794 |
0.37321244 |
NSC 646159 |
Null |
0.0139796580235794 |
0.65651815 |
NSC 658143 |
2-(1-(4-(2-(2-Hydroxyethoxy)ethyl)piperazino))naphthazarin |
0.0139796580235794 |
0.44858396 |
NSC 659390 |
Null |
0.0139796580235794 |
0.61117598 |
NSC 665622 |
Cyclohexanone, 2,6-bis[(1-pyrrolidinyl)methyl]-, dihydrochloride |
0.0139796580235794 |
0.65326846 |
NSC 666034 |
Carquniostatin B |
0.0139796580235794 |
0.68613701 |
NSC 669146 |
6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- |
0.0139796580235794 |
0.46669161 |
NSC 674276 |
Pyrazino[1,2-a]benzimidazole, 1,3-diphenyl- |
0.0139796580235794 |
-0.47191547 |